PATENT CLAIM ANALYSIS

Application Number: 16249133
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "045000"]

Abstract:
A pharmaceutical solution for a medication delivery apparatus, especially a metered dose inhaler, is described. The pharmaceutical solution comprises: (a) a liquefied propellant component consisting essentially of and preferably consisting entirely of 1,1-difluoroethane (R-152a); (b) ethanol; and (c) a drug component dissolved in the propellant/ethanol mixture consisting of at least one drug selected from the group consisting of beclomethasone dipropionate (BDP) and fluticasone propionate (FP).

Claim (Index 10):
A pharmaceutical solution for delivery using a medication delivery apparatus to treat a respiratory disorder comprising:\n (a) a liquefied propellant component consisting essentially of 1,1-difluoroethane (R-152a); (b) 1.0 to 20.0 weight % of ethanol based on a total weight of the pharmaceutical solution; and (c) 0.01 to 4.0 weight % of a drug component dissolved in the pharmaceutical solution consisting of at least one corticosteroid.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.55556
- Patent Class: 424.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15250319', '15270519', '15357279', '14351001', '14351075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8000288400796526
- 35 USC 102 Novelty (BERT): 0.6010483291226131
- Combined Prediction Score: 0.7801307889839486
- Mean Citation Score: 413.094418
- Max Citation Score: 511.73163
- Similarity Product: 495.4705960884602

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test